Polku Therapeutics Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.99M

  • Investors
  • 4

Polku Therapeutics General Information

Description

Developer of diseases treatments focused drugs designed to treat neurodegenerative disorders. The company utilizes a virtual drug development model that combines cost efficiency with high adaptability while collaborating with experts and leveraging global resources, enabling researchers and clinicians to offer new treatment options for conditions like Parkinson's disease and Alzheimer's.

Contact Information

Website
www.polkutx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Haartmaninkatu 4
  • 00290 Helsinki
  • Finland
+358 040
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Haartmaninkatu 4
  • 00290 Helsinki
  • Finland
+358 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Polku Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 15-Sep-2024 $2.99M Completed Generating Revenue
1. University Spin-Out 01-Jan-2024 Completed Generating Revenue
To view Polku Therapeutics’s complete valuation and funding history, request access »

Polku Therapeutics Patents

Polku Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023262617-A1 Prep binding ligands Pending 29-Apr-2022
EP-4514781-A1 Prep binding ligands Pending 29-Apr-2022
US-20250288559-A1 Prep binding ligands Pending 29-Apr-2022 A61K31/4196

Polku Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Polku Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital
Innovestor Venture Capital Minority
Torrey Pines Investment Venture Capital Minority
University of Helsinki University Minority
To view Polku Therapeutics’s complete investors history, request access »

Polku Therapeutics FAQs

  • When was Polku Therapeutics founded?

    Polku Therapeutics was founded in 2024.

  • Where is Polku Therapeutics headquartered?

    Polku Therapeutics is headquartered in Helsinki, Finland.

  • What is the size of Polku Therapeutics?

    Polku Therapeutics has 5 total employees.

  • What industry is Polku Therapeutics in?

    Polku Therapeutics’s primary industry is Drug Discovery.

  • Is Polku Therapeutics a private or public company?

    Polku Therapeutics is a Private company.

  • What is Polku Therapeutics’s current revenue?

    The current revenue for Polku Therapeutics is .

  • How much funding has Polku Therapeutics raised over time?

    Polku Therapeutics has raised $2.99M.

  • Who are Polku Therapeutics’s investors?

    Alzheimers Drug Discovery Foundation, Innovestor, Torrey Pines Investment, and University of Helsinki have invested in Polku Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process